ABOUT MENINGITIS B

Facts about meningococcal disease

Icon of bacteria

Meningococcal disease is an uncommon but potentially life-threatening bacterial infection. It affects the lining of the brain and spinal cord and can also result in sepsis (sometimes called “blood poisoning”).

It can be challenging to diagnose because early symptoms are similar to a cold or flu. Symptoms progress quickly and can lead to death within 24-48 hours.

Icon of map

Meningitis B* has caused the majority of all cases of invasive meningococcal disease (IMD) in Canada since the early 2000s. From 2013-2017, the incidence of Meningitis B* was highest amongst infants <1 year of age.

Icon of infant

In infants and young children, 80% of IMD cases were associated with serogroup B.

Find out where you can get the meningitis B† vaccination by using the clinic finder below.

Baby in tub

How is meningococcal disease spread?

Icon of bacteria

The bacteria that cause IMD may spread through close contact with other people. Examples include but are not limited to:

  • Coughing and sneezing
  • Kissing or close physical contact
  • Sharing eating utensils and drinking glasses
Icon of people

Some people can carry the Neisseria meningitidis bacteria without developing the disease.

  • An individual infected with meningococcal bacteria can spread the disease up to 7 days before showing symptoms of meningococcal disease.
  • Up to 1 in 10 healthy people are carriers of the infection and may remain a carrier for up to 6 months without any symptoms.

Because preventing the spread of germs—especially among children and adolescents—is nearly impossible, vaccination becomes an important consideration.

BEXSERO is a vaccine, for individuals from 2 months through 25 years of age, for the prevention of meningococcal disease caused by the Neisseria meningitidis group B bacteria.

What are the symptoms?

Icon of thermometer

Because symptoms begin mildly, like a cold or flu (e.g., fever, headache, aches and pains in joints and muscles), they can be difficult to diagnose.

Icon of 1 in 10

Up to 1 in 10 patients die (typically within 24 to 48 hours after the onset of symptoms).§

Icon of one third

Of those who recover, up to 1 in 3 patients experience serious complicationsincluding hearing loss, neurologic disabilities and amputations

Meningococcal disease starts quickly and may progress within 24 hours to serious, possibly life-threatening infections.§

Teen running

Talk to your doctor about vaccination against meningitis B.* Find out where you can get a meningitis B* vaccine for your child by using the clinic finder below.

* Meningococcal disease caused by Neisseria meningitidis group B strains.

† BEXSERO is not expected to provide protection against all circulating meningococcal serogroup B strains and does not offer protection against strains A, C, Y, and W-135.

‡ BEXSERO is indicated for individuals as early as 2 months through 25 years of age. 

§ BEXSERO does not treat or reduce the consequences of meningococcal disease, including meningitis, sepsis and death.